期刊
CANCER CELL
卷 28, 期 6, 页码 687-689出版社
CELL PRESS
DOI: 10.1016/j.ccell.2015.11.010
关键词
-
资金
- Wellcome Trust [095688] Funding Source: Medline
- Wellcome Trust [095688/Z/11/Z] Funding Source: Wellcome Trust
- BBSRC [BB/I005609/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/I005609/1] Funding Source: researchfish
- Wellcome Trust [095688/Z/11/Z] Funding Source: researchfish
Gut microbes have ascended to prominence as key modulators of host immunity, raising the possibility that they could influence the outcome of cancer immunotherapy. Two recent studies address this question by identifying specific gut-resident bacteria as drivers of checkpoint blockade immunotherapy in pre-clinical tumor models.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
